Iznardo, H, Puig, L. Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypes. CURRENT OPINION IN RHEUMATOLOGY. 2022; 34(4)DOI:10.1097/BOR.0000000000000882. PMID:35699337. IF:5.100(Q2/3D).

Serra-Baldrich, E, Santamaria-Babi, LF, Silvestre, JF. Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis. Actas Dermo-Sifiliograficas. 2022; 113(7)DOI:10.1016/j.ad.2021.12.014. PMID:35842249. IF:(Q/D).

Chabra, S, Gill, BJ, Gallo, G, Zhu, DT, Pitou, C, Payne, CD, Accioly, A, Puig, L. Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials. ADVANCES IN THERAPY. 2022; 39(6)DOI:10.1007/s12325-022-02126-0. PMID:35449322. IF:3.800(Q2/4D).

Medina-Catalan, D, Riera, P, Pages-Puigdemont, N, Masip, M, Lopez-Ferrer, A, Vilarrasa, E, Puig, L. A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence. International Journal of Clinical Pharmacy. 2022; 44(3)DOI:10.1007/s11096-022-01400-z. PMID:35380392. IF:2.400(Q3/8D).

de Bruin-Weller, MS, Serra-Baldrich, E, Barbarot, S, Grond, S, Schuster, C, Petto, H, Capron, JP, Raibouaa, A, Werfel, T. Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis. Dermatology and Therapy. 2022; 12(6)DOI:10.1007/s13555-022-00734-w. PMID:35543919. IF:3.400(Q2/3D).

Sanz, C, Nomdedeu, M, Pereira, A, Sauleda, S, Alonso, R, Bes, M, Brillembourg, H, Garcia-Vidal, C, Millan, A, Martinez-Llonch, N, Piron, M, Puerta-Alcalde, P, Puig, L, Rico, V, Soriano, A. Efficacy of early transfusion of convalescent plasma with high-titer SARS-CoV-2 neutralizing antibodies in hospitalized patients with COVID-19. TRANSFUSION. 2022; 62(5)DOI:10.1111/trf.16863. PMID:35338710. IF:2.900(Q3/7D).

Puig, L, Costanzo, A, Munoz-Elias, EJ, Jazra, M, Wegner, S, Paul, CF, Conrad, C. The biological basis of disease recurrence in psoriasis: a historical perspective and current models. BRITISH JOURNAL OF DERMATOLOGY. 2022; 186(5)DOI:10.1111/bjd.20963. PMID:34939663. IF:10.300(Q1/1D).

Zozaya, N, Villoro, R, Abdalla, F, Alfonso Zamora, S, Balea Filgueiras, J, Carrascosa Carrillo, JM, Delgado Sanchez, O, Dolz Sinisterra, F, Garcia-Ruiz, A, Herranz Pinto, P, Manfredi, A, Martinez Olmos, J, Morales De los Rios Luna, P, Puig Sanz, L, Ros, S, Hildago-Vega, A. Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation. ACTA DERMATO-VENEREOLOGICA. 2022; 102DOI:10.2340/actadv.v102.583. PMID:35312022. IF:3.600(Q1/3D).

Canal-Garcia, E, Bosch-Amate, X, Belinchon, I, Puig, L. Nail Psoriasis. Actas Dermo-Sifiliograficas. 2022; 113(5)DOI:10.1016/j.ad.2022.01.006. PMID:35697407. IF:(Q/D).

Medrano, RM, Estebaranz, JLL, Sanmartin-Jimenez, O, Garces, JR, Rodriguez-Prieto, MA, Vilarrasa-Rull, E, De Eusebio-Murillo, E, Escutia-Munoz, B, Florez-Menendez, A, Artola-Igarza, JL, Alfaro-Rubio, A, Redondo, P, Delgado-Jimenez, Y, Sanchez-Schmidt, JM, Allende-Markixana, I, Alonso-Pacheco, ML, Garcia-Bracamonte, B, De la Cueva-Dobao, P, Navarro-Tejedor, R, Ciudad-Blanco, C, Carnero-Gonzalez, L, Vazquez-Veiga, H, Cano-Martinez, N, Ruiz-Salas, V, Sanchez-Sambucety, P, Botella-Estrada, R, Gonzalez-Sixto, B, Martorell-Calatayud, A, Gil, P, Morales-Gordillo, V, Toll-Abello, A, Ocerin-Guerra, I, Mayor-Arenal, M, Suarez-Fernandez, R, Sainz-Gaspar, L, Descalzo, MA, Garcia-Doval, I. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer - Basal Cell Carcinoma or Squamous Cell Carcinoma - Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study. Actas Dermo-Sifiliograficas. 2022; 113(5)DOI:10.1016/j.ad.2022.01.035. PMID:. IF:(Q/D).

Blauvelt, A, Tsai, TF, Langley, RG, Miller, M, Shen, YK, You, Y, Yang, YW, Papp, KA, Puig, L. Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2022; 86(4)DOI:10.1016/j.jaad.2021.11.004. PMID:34798201. IF:13.800(Q1/1D).

Vidal, S, Puig, L, Carrascosa-Carrillo, JM, Gonzalez-Cantero, A, Ruiz-Carrascosa, JC, Velasco-Pastor, AM. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment (vol 22, 6740, 2021). INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(5)DOI:10.3390/ijms23052649. PMID:35270045. IF:5.600(Q1/3D).

Bes, M, Costafreda, MI, Riveiro-Barciela, M, Piron, M, Rico, A, Quer, J, Puig, L, Sauleda, S. Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017-2020. EMERGING INFECTIOUS DISEASES. 2022; 28(1)DOI:10.3201/eid2801.211466. PMID:34932460. IF:11.800(Q1/1D).

Gimenez-Arnau, A, Bartra, J, Ferrer, M, Jauregui, I, Borbujo, J, Figueras, I, Munoz-Bellido, F, Pedraz, J, Serra-Baldrich, E, Tejedor-Alonso, M, Velasco, M, Terradas, P, Labrador, M. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2022; 32(3)DOI:10.18176/jiaci.0661. PMID:33349612. IF:7.200(Q1/2D).

Gisondi P., Simon D., Alarcon I., Pournara E., Puig L.. Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review. JOURNAL OF DERMATOLOGICAL TREATMENT. 2023; 34(1)DOI:10.1080/09546634.2023.2167487. PMID:36625506. IF:2.900(Q2/4D).

Mateu-Arrom, L, Rusinol, L, Puig, L. Reddish and edematous nodules in an immunosuppressed patient. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2023; 62(7)DOI:10.1111/ijd.16512. PMID:36371702. IF:3.500(Q1/3D).

Rusinol, L, Carmona-Rocha, E, Spertino, J. Bullous eruption in a pluripathological patient. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2023; 62(5)DOI:10.1111/ijd.16590. PMID:36683133. IF:3.500(Q1/3D).

Gely C., Gordillo J., Bertoletti F., González-Muñoza C., López A., García-Planella E.. Perception of the need for dietary advice and dietary modifications in inflammatory bowel disease patients. Gastroenterologia y Hepatologia. 2023; 46(5)DOI:10.1016/j.gastrohep.2022.10.005. PMID:36243252. IF:2.200(Q3/6D).

Puig L., Choon S.E., Gottlieb A.B., Marrakchi S., Prinz J.C., Romiti R., Tada Y., von Bredow D., Gooderham M.. Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(4)DOI:10.1111/jdv.18851. PMID:36606566. IF:8.500(Q1/1D).

Docampo-Simon, A, Sanchez-Pujol, MJ, Pastor-Nieto, MA, Gimenez-Arnau, A, Rodriguez-Serna, M, Serra-Baldrich, E, Miquel, J, Sanchez-Perez, J, Sanz-Sanchez, T, Zaragoza-Ninet, V, Sanchez-Pedreno, P, Carrascosa, JM, Gatica-Ortega, ME, Fernandez-Redondo, V, Cordoba-Guijarro, S, Gonzalez-Perez, R, Silvestre, JF. Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain. Dermatitis. 2023; 34(4)DOI:10.1089/derm.2022.0023. PMID:37001174. IF:4.000(Q1/2D).